Galectin-9 treatment is cytotoxic for B cell lymphoma by disrupting autophagy.

Saved in:
Bibliographic Details
Title: Galectin-9 treatment is cytotoxic for B cell lymphoma by disrupting autophagy.
Authors: Koll L; Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands., Lourens HJ; Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands., Marsman G; Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands., de Haan S; Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands., Niki T; Department of Immunology, Kagawa University, Takamatsu, Kagawa, Japan., Huls GA; Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands., Bremer E; Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands., Wiersma VR; Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands.
Source: Frontiers in pharmacology [Front Pharmacol] 2025 Jun 26; Vol. 16, pp. 1601235. Date of Electronic Publication: 2025 Jun 26 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40641998
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Galectin-9 treatment is cytotoxic for B cell lymphoma by disrupting autophagy.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Koll+L%22">Koll L</searchLink>; Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands.<br /><searchLink fieldCode="AU" term="%22Lourens+HJ%22">Lourens HJ</searchLink>; Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands.<br /><searchLink fieldCode="AU" term="%22Marsman+G%22">Marsman G</searchLink>; Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands.<br /><searchLink fieldCode="AU" term="%22de+Haan+S%22">de Haan S</searchLink>; Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands.<br /><searchLink fieldCode="AU" term="%22Niki+T%22">Niki T</searchLink>; Department of Immunology, Kagawa University, Takamatsu, Kagawa, Japan.<br /><searchLink fieldCode="AU" term="%22Huls+GA%22">Huls GA</searchLink>; Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands.<br /><searchLink fieldCode="AU" term="%22Bremer+E%22">Bremer E</searchLink>; Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands.<br /><searchLink fieldCode="AU" term="%22Wiersma+VR%22">Wiersma VR</searchLink>; Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101548923%22">Frontiers in pharmacology</searchLink> [Front Pharmacol] 2025 Jun 26; Vol. 16, pp. 1601235. <i>Date of Electronic Publication: </i>2025 Jun 26 (<i>Print Publication: </i>2025).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Media]%22">Frontiers Media] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101548923 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1663-9812 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216639812%22">16639812 </searchLink><i>NLM ISO Abbreviation: </i>Front Pharmacol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40641998
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fphar.2025.1601235
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1601235
    Titles:
      – TitleFull: Galectin-9 treatment is cytotoxic for B cell lymphoma by disrupting autophagy.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Koll L
      – PersonEntity:
          Name:
            NameFull: Lourens HJ
      – PersonEntity:
          Name:
            NameFull: Marsman G
      – PersonEntity:
          Name:
            NameFull: de Haan S
      – PersonEntity:
          Name:
            NameFull: Niki T
      – PersonEntity:
          Name:
            NameFull: Huls GA
      – PersonEntity:
          Name:
            NameFull: Bremer E
      – PersonEntity:
          Name:
            NameFull: Wiersma VR
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 26
              M: 06
              Text: 2025 Jun 26
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 1663-9812
          Numbering:
            – Type: volume
              Value: 16
          Titles:
            – TitleFull: Frontiers in pharmacology
              Type: main
ResultId 1